Detalhe da pesquisa
1.
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
Cancer Chemother Pharmacol
; 60(5): 725-32, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17273825
2.
Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer.
Urol Oncol
; 22(1): 32-5, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-14969801
3.
Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.
J Geriatr Oncol
; 4(2): 114-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071536
4.
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
J Natl Cancer Inst
; 100(11): 805-14, 2008 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18505968
5.
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).
Anticancer Drugs
; 18(10): 1201-6, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17893521
6.
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Lancet Oncol
; 8(3): 219-25, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17329192
7.
Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
Anticancer Drugs
; 15(5): 489-94, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15166623